Prof. Dr. med. Dominique de Quervain Department of Biomedicine Profiles & Affiliations OverviewResearch Publications Projects & Collaborations Projects & Collaborations OverviewResearch Publications Projects & Collaborations Profiles & Affiliations Projects & Collaborations 33 foundShow per page10 10 20 50 Development of small molecule MSI1/2 inhibitors to treat memory disorders Research Project | 2 Project MembersImported from Grants Tool 4708786 Developing a reward-based biofeedback application for depressed patients using virtual reality Research Project | 1 Project MembersImported from Grants Tool 4695263 Examining mental representations of contamination stimuli in a population with obsessive-compulsive disorder, a data-driven approach Research Project | 2 Project MembersExposure with response prevention (ERP) is the gold standard for treating obsessive-compulsive disorder (OCD) and is recommended by national and international treatment guidelines. Despite recent developments in this approach, a large share of patients remains symptomatic after treatment, discontinue treatment or are reluctant to start treatment at all. One reason might be that the stimulus material used during ERP is not tailored to the patient, so it does not necessarily target the relevant dimensions of the OCD symptomatology. Currently, there exists no contamination OCD (C-OCD) stimuli set that is validated to provoke other emotions than anxiety, that offers a wide range of intensities along different emotions. It is conceivable that other dimensions of the stimuli are of relevance than the theory-driven dimensions rooted in preexisting emotional theories that represent a fixed model of mental representations, and therefore might miss important unknown domain specific dimensions that might be of higher relevance for some patients. This project intends to complement theory-driven approaches by a data-driven approach to identify relevant dimensions of C-OCD triggers by exploring their mental representations. Methodologically, crowdsourced similarity judgements will be implemented that will be analyzed with multidimensional scaling to identify underlying dimensions followed by a crowdsourced dimension-naming task. Further characterizing C-OCD stimuli and their mental representations as well as compiling a freely available database of contamination-OCD cues will inform the design of new personalized ERP approaches that counteract common problems of ERP treatments for OCD. Oxytocin substitution therapy in patients with central diabetes insipidus: a double-blind randomized-controlled trial the OxyTUTION trial Research Project | 2 Project MembersNo Description available Feasibility study on the use of Ze 91019 on day-time cognition and quality of life in people with occasional sleep problems Research Project | 2 Project MembersIt is well known that cognitive performance and quality of life can be impaired after nights of little or no sleep (Hudson, 2020) (Roth, 2007). Therefore, people with occasional sleep problems, i.e. with 1-2 nights per week with impaired sleep, can suffer from impaired cognition the following day. Moreover, occasional sleep problems may lead to reduced overall quality of life (Buysse, 2007). Many people with insomnia do not wish to use conventional hypnotic drugs because of concerns about side effects and the risks of tolerance and dependence, and others do not want to spend the time and efforts required with behavioral therapies (Vincent, 2001). Thus, there is an increasing interest in the use of complementary and alternative medicines, such as herbal and dietary supplements, partly because of their natural properties and perceived relative absence of residual effects. Valerian and hop have both been an integral part of traditional medicine for Centuries. Pharmacological and clinical studies are available demonstrating the applicability of Redormin ® 500, a 45% methanolic extract from valerian root and from hop strobiles, in sleep disorders (Abourashed, 2004), (Dimpfel, 2006), (Morin, 2005), (Koetter, 2007). Not only could the effect be visualized through EEG measurements, but also new ideas regarding the mechanism of action were brought forth (Koetter, 2007)). Currently an agonistic effect on central adenosine receptors, and thus a counteracting effect on caffeine induced sleeplessness through the lignans in hydrophilic valerian root extracts is discussed as a potential mechanism of action for valerian root extract (Schumacher, 2002). The studies available mainly focused on the improvement of sleep quality rather than on improvements of cognitive performance and day performance. Therefore, the aim of this feasibility study is to determine the effect of Redormin® 500 on day-time cognition and quality of life in people with occasional sleep problems. Simulation Hallucinations Using Mixed Reality Research Project | 2 Project MembersBackground: Reality discrimination (RD), the ability to discriminate between perception and imagination, is central to the assessment of psychiatric health, especially in the context of psychotic disorders. Impairments in RD are associated with auditory and visual hallucination proneness in patients with psychotic disorders as well as the general population. However, there are currently no instruments available that allow for the combined assessment of auditory and visual RD performance. Furthermore, RD paradigms are limited in their ability to account for the complex phenomenology of natural hallucinations. More sensitive assessment methods are crucial to improve patient care, diagnosis, and treatment. Objectives: The overall goal of the proposed research is to develop a dual-modality RD paradigm to investigate the cognitive mechanisms underlying visual and auditory hallucinations and their relation to psychotic disorders. The first objective is to simulate hallucinatory perceptual experiences using a novel immersive technology method to manipulate the visual and auditory perception of natural environments. The second objective is to extend this simulation into a dual-modality RD paradigm based on the signal detection framework. Thereafter, the RD paradigm will be applied in healthy adults from the general population (Objective 3) and patients diagnosed with psychotic disorder (Objective 4). Methods: A first study will test the hypothesis that visual and auditory RD performance is associated with hallucination proneness in the general population (N=100). A second study will evaluate visual and auditory RD performance in a sample of patients with psychotic disorders (N=30) and will test the hypothesis that these patients are impaired in RD relative to matched controls from Study 1. In both studies, participants will complete the newly-designed RD paradigm as well as assessments of hallucination proneness and predisposition to psychosis (Study 1) or psychosis severity (Study 2). Expected Value of the Proposed Project: This research will contribute to the understanding of visual and auditory hallucinations and their shared cognitive mechanisms in the general population and patients with psychotic disorders. The novel RD paradigm may provide an improved measure of psychosis proneness that is more objective and behaviorally sensitive to hallucinatory experiences. This research may have important implications for the assessment, treatment, and early detection of psychotic disorders and will provide an ecologically valid framework from which innovative psychological interventions can be developed. Genome-guided drug identification: A randomized placebo-controlled trial on the influence of fampridine on working memory Research Project | 2 Project MembersBackground: The discrepancy between the urgent need for improved therapeutic compounds and the lack of significant development of novel drugs illustrates the importance of pursuing new strategies aimed at identifying druggable targets related to psychiatric disease. Recent advances in large-scale genetic studies suggest that human genetic discoveries have the potential of translating into novel treatment targets for psychiatric conditions. Aim: To implement a drug repurposing strategy and perform a proof-of-concept clinical trial on the influence of a potassium channel blocker (fampridine) on working memory performance, an intermediate trait of psychiatric disorders. Methods: Guided by recent genetic findings in schizophrenia, we focus on those loci that point to genes targeted by currently approved drugs. As starting point serves the large schizophrenia genome-wide association study that provided genes robustly linked to the risk for the disorder. As intermediate filtering layer serves working memory performance, which is a well-established intermediate phenotype for schizophrenia. Finally, one repurposing candidate, fampridine, is selected and tested for its putative influence on working memory performance in the framework of a randomized placebo-controlled trial in healthy subjects. Expected value: We anticipate that the exponentially increased genetic knowledge of psychiatric disorders together with the use of biologically-informed phenotypes and appropriate data-mining methodology will be a starting point for the identification of novel drug targets and treatments, i.e. the very goal of the present proposal. Should the current randomized control trial turn out positive, it might open new avenues for the treatment of cognitive symptoms in psychiatric disorders with known and hopefully also new and specific potassium channel blockers. Effects of an exercise and sport intervention among refugees living in a Greek refugee camp: A randomized controlled trial Research Project | 10 Project MembersDue to ongoing political and social conflicts, the number of international refugees has been increasing. Refugees are exposed to severe mental and physical strain, as well as traumatic experiences during their flight. As a consequence, the risk of psychiatric disorders is markedly increased among international refugees with particularities based on gender. International organizations have criticized the lack of early interventions as a key problem, because untreated mental disorders are often difficult to cure at a later stage. Today, exercise and sport have been successfully employed to treat a wide range of psychiatric disorders. With PTSD patients, however, very limited empirical evidence exists, and studies carried out with international refugees are nearly non-existent. In 2017, we have implemented a first pilot one-group pre-test/post-test study in a Greek refugee camp, corroborating the potential benefits of exercise and sport on refugees' mental health and fitness. The proposed study will take place in the Koutsochero refugee camp, located close to the city of Larissa (Greece). The randomized controlled trial will include an exercise and sport intervention group (n=68) and a wait-list control group (n=68). Participants (50% men/women, 16-59 years) will be assessed three times at baseline, immediately post-intervention (after 3 months), and follow-up (after 6 months). In the second year of study, the program will be opened to all camp residents. Exercise and sport will be offered five times per week (60 min/session) for three months. Participants will participate in at least two sessions per week. The program is developed according to the participants' needs and preferences and they will be able to choose between a range of activities. PTSD symptoms will serve as primary outcome. Several secondary outcomes will be assessed, and the project will identify potential gender issues. A strategy will be developed how the exercise and sport program can be continued after the SNIS funding comes to an end, and how the program can be scaled up beyond the borders of the Koutsochero camp. Learning from the extraordinary: The molecular underpinnings of extreme memorizers Research Project | 2 Project MembersStellen Sie sich vor, Sie könnten sich für jedes Datum seit Jahrzehnten an den Wochentag erinnern und sich wüssten noch, was Sie an jedem dieser Tage getan haben. Was unmöglich klingt, existiert tatsächlich als extrem seltener Befund, genannt Highly Superior Autobiographical Memory (HSAM). Derzeit sind weltweit rund 60 Personen mit HSAM bekannt. Wir werden eine eingehende genetische Analyse von HSAM Individuen durchführen, um den molekularen Mechanismus zu suchen, der diesem extrem stabilen Gedächtnis zugrunde liegt. Bei Erfolg könnten die Ergebnisse unser Verständnis des Gedächtnisses verändern und neue Wege zur Behandlung von Gedächtnisstörungen eröffnen. Population-wide screens of the immune repertoire: a reverse personalized-medicine approach Research Project | 2 Project MembersAntibodies are crucial for the intact function of the human immune system. For example, they are responsible for the body's defense against bacteria and cancer cells, but are also implicated in a variety of neuropsychiatric disorders. The present driver-project aims at identifying rare antibodies that will help elucidating mechanisms of disease and help identifying suitable targets for drug discovery. This will be achieved by an unprecedented high-throughput search for auto-antibodies in blood samples of thousands of participants. The Transfaculty Research Platform Molecular and Cognitive Neurosciences represents Basel's involvement in this Zurich-Basel alliance project. The Platform contributes with a unique combination of functional and structural brain imaging, genetic, behavioral, and biological data from thousands of healthy young participants who underwent detailed neuropsychological assessments. The intelligent interconnection of this database information with the data arising from the large, unselected patient cohort of the University Hospital Zurich will be crucial for the informed decisions that will result in the prioritization of novel drug targets. 1234 1...4 OverviewResearch Publications Projects & Collaborations
Projects & Collaborations 33 foundShow per page10 10 20 50 Development of small molecule MSI1/2 inhibitors to treat memory disorders Research Project | 2 Project MembersImported from Grants Tool 4708786 Developing a reward-based biofeedback application for depressed patients using virtual reality Research Project | 1 Project MembersImported from Grants Tool 4695263 Examining mental representations of contamination stimuli in a population with obsessive-compulsive disorder, a data-driven approach Research Project | 2 Project MembersExposure with response prevention (ERP) is the gold standard for treating obsessive-compulsive disorder (OCD) and is recommended by national and international treatment guidelines. Despite recent developments in this approach, a large share of patients remains symptomatic after treatment, discontinue treatment or are reluctant to start treatment at all. One reason might be that the stimulus material used during ERP is not tailored to the patient, so it does not necessarily target the relevant dimensions of the OCD symptomatology. Currently, there exists no contamination OCD (C-OCD) stimuli set that is validated to provoke other emotions than anxiety, that offers a wide range of intensities along different emotions. It is conceivable that other dimensions of the stimuli are of relevance than the theory-driven dimensions rooted in preexisting emotional theories that represent a fixed model of mental representations, and therefore might miss important unknown domain specific dimensions that might be of higher relevance for some patients. This project intends to complement theory-driven approaches by a data-driven approach to identify relevant dimensions of C-OCD triggers by exploring their mental representations. Methodologically, crowdsourced similarity judgements will be implemented that will be analyzed with multidimensional scaling to identify underlying dimensions followed by a crowdsourced dimension-naming task. Further characterizing C-OCD stimuli and their mental representations as well as compiling a freely available database of contamination-OCD cues will inform the design of new personalized ERP approaches that counteract common problems of ERP treatments for OCD. Oxytocin substitution therapy in patients with central diabetes insipidus: a double-blind randomized-controlled trial the OxyTUTION trial Research Project | 2 Project MembersNo Description available Feasibility study on the use of Ze 91019 on day-time cognition and quality of life in people with occasional sleep problems Research Project | 2 Project MembersIt is well known that cognitive performance and quality of life can be impaired after nights of little or no sleep (Hudson, 2020) (Roth, 2007). Therefore, people with occasional sleep problems, i.e. with 1-2 nights per week with impaired sleep, can suffer from impaired cognition the following day. Moreover, occasional sleep problems may lead to reduced overall quality of life (Buysse, 2007). Many people with insomnia do not wish to use conventional hypnotic drugs because of concerns about side effects and the risks of tolerance and dependence, and others do not want to spend the time and efforts required with behavioral therapies (Vincent, 2001). Thus, there is an increasing interest in the use of complementary and alternative medicines, such as herbal and dietary supplements, partly because of their natural properties and perceived relative absence of residual effects. Valerian and hop have both been an integral part of traditional medicine for Centuries. Pharmacological and clinical studies are available demonstrating the applicability of Redormin ® 500, a 45% methanolic extract from valerian root and from hop strobiles, in sleep disorders (Abourashed, 2004), (Dimpfel, 2006), (Morin, 2005), (Koetter, 2007). Not only could the effect be visualized through EEG measurements, but also new ideas regarding the mechanism of action were brought forth (Koetter, 2007)). Currently an agonistic effect on central adenosine receptors, and thus a counteracting effect on caffeine induced sleeplessness through the lignans in hydrophilic valerian root extracts is discussed as a potential mechanism of action for valerian root extract (Schumacher, 2002). The studies available mainly focused on the improvement of sleep quality rather than on improvements of cognitive performance and day performance. Therefore, the aim of this feasibility study is to determine the effect of Redormin® 500 on day-time cognition and quality of life in people with occasional sleep problems. Simulation Hallucinations Using Mixed Reality Research Project | 2 Project MembersBackground: Reality discrimination (RD), the ability to discriminate between perception and imagination, is central to the assessment of psychiatric health, especially in the context of psychotic disorders. Impairments in RD are associated with auditory and visual hallucination proneness in patients with psychotic disorders as well as the general population. However, there are currently no instruments available that allow for the combined assessment of auditory and visual RD performance. Furthermore, RD paradigms are limited in their ability to account for the complex phenomenology of natural hallucinations. More sensitive assessment methods are crucial to improve patient care, diagnosis, and treatment. Objectives: The overall goal of the proposed research is to develop a dual-modality RD paradigm to investigate the cognitive mechanisms underlying visual and auditory hallucinations and their relation to psychotic disorders. The first objective is to simulate hallucinatory perceptual experiences using a novel immersive technology method to manipulate the visual and auditory perception of natural environments. The second objective is to extend this simulation into a dual-modality RD paradigm based on the signal detection framework. Thereafter, the RD paradigm will be applied in healthy adults from the general population (Objective 3) and patients diagnosed with psychotic disorder (Objective 4). Methods: A first study will test the hypothesis that visual and auditory RD performance is associated with hallucination proneness in the general population (N=100). A second study will evaluate visual and auditory RD performance in a sample of patients with psychotic disorders (N=30) and will test the hypothesis that these patients are impaired in RD relative to matched controls from Study 1. In both studies, participants will complete the newly-designed RD paradigm as well as assessments of hallucination proneness and predisposition to psychosis (Study 1) or psychosis severity (Study 2). Expected Value of the Proposed Project: This research will contribute to the understanding of visual and auditory hallucinations and their shared cognitive mechanisms in the general population and patients with psychotic disorders. The novel RD paradigm may provide an improved measure of psychosis proneness that is more objective and behaviorally sensitive to hallucinatory experiences. This research may have important implications for the assessment, treatment, and early detection of psychotic disorders and will provide an ecologically valid framework from which innovative psychological interventions can be developed. Genome-guided drug identification: A randomized placebo-controlled trial on the influence of fampridine on working memory Research Project | 2 Project MembersBackground: The discrepancy between the urgent need for improved therapeutic compounds and the lack of significant development of novel drugs illustrates the importance of pursuing new strategies aimed at identifying druggable targets related to psychiatric disease. Recent advances in large-scale genetic studies suggest that human genetic discoveries have the potential of translating into novel treatment targets for psychiatric conditions. Aim: To implement a drug repurposing strategy and perform a proof-of-concept clinical trial on the influence of a potassium channel blocker (fampridine) on working memory performance, an intermediate trait of psychiatric disorders. Methods: Guided by recent genetic findings in schizophrenia, we focus on those loci that point to genes targeted by currently approved drugs. As starting point serves the large schizophrenia genome-wide association study that provided genes robustly linked to the risk for the disorder. As intermediate filtering layer serves working memory performance, which is a well-established intermediate phenotype for schizophrenia. Finally, one repurposing candidate, fampridine, is selected and tested for its putative influence on working memory performance in the framework of a randomized placebo-controlled trial in healthy subjects. Expected value: We anticipate that the exponentially increased genetic knowledge of psychiatric disorders together with the use of biologically-informed phenotypes and appropriate data-mining methodology will be a starting point for the identification of novel drug targets and treatments, i.e. the very goal of the present proposal. Should the current randomized control trial turn out positive, it might open new avenues for the treatment of cognitive symptoms in psychiatric disorders with known and hopefully also new and specific potassium channel blockers. Effects of an exercise and sport intervention among refugees living in a Greek refugee camp: A randomized controlled trial Research Project | 10 Project MembersDue to ongoing political and social conflicts, the number of international refugees has been increasing. Refugees are exposed to severe mental and physical strain, as well as traumatic experiences during their flight. As a consequence, the risk of psychiatric disorders is markedly increased among international refugees with particularities based on gender. International organizations have criticized the lack of early interventions as a key problem, because untreated mental disorders are often difficult to cure at a later stage. Today, exercise and sport have been successfully employed to treat a wide range of psychiatric disorders. With PTSD patients, however, very limited empirical evidence exists, and studies carried out with international refugees are nearly non-existent. In 2017, we have implemented a first pilot one-group pre-test/post-test study in a Greek refugee camp, corroborating the potential benefits of exercise and sport on refugees' mental health and fitness. The proposed study will take place in the Koutsochero refugee camp, located close to the city of Larissa (Greece). The randomized controlled trial will include an exercise and sport intervention group (n=68) and a wait-list control group (n=68). Participants (50% men/women, 16-59 years) will be assessed three times at baseline, immediately post-intervention (after 3 months), and follow-up (after 6 months). In the second year of study, the program will be opened to all camp residents. Exercise and sport will be offered five times per week (60 min/session) for three months. Participants will participate in at least two sessions per week. The program is developed according to the participants' needs and preferences and they will be able to choose between a range of activities. PTSD symptoms will serve as primary outcome. Several secondary outcomes will be assessed, and the project will identify potential gender issues. A strategy will be developed how the exercise and sport program can be continued after the SNIS funding comes to an end, and how the program can be scaled up beyond the borders of the Koutsochero camp. Learning from the extraordinary: The molecular underpinnings of extreme memorizers Research Project | 2 Project MembersStellen Sie sich vor, Sie könnten sich für jedes Datum seit Jahrzehnten an den Wochentag erinnern und sich wüssten noch, was Sie an jedem dieser Tage getan haben. Was unmöglich klingt, existiert tatsächlich als extrem seltener Befund, genannt Highly Superior Autobiographical Memory (HSAM). Derzeit sind weltweit rund 60 Personen mit HSAM bekannt. Wir werden eine eingehende genetische Analyse von HSAM Individuen durchführen, um den molekularen Mechanismus zu suchen, der diesem extrem stabilen Gedächtnis zugrunde liegt. Bei Erfolg könnten die Ergebnisse unser Verständnis des Gedächtnisses verändern und neue Wege zur Behandlung von Gedächtnisstörungen eröffnen. Population-wide screens of the immune repertoire: a reverse personalized-medicine approach Research Project | 2 Project MembersAntibodies are crucial for the intact function of the human immune system. For example, they are responsible for the body's defense against bacteria and cancer cells, but are also implicated in a variety of neuropsychiatric disorders. The present driver-project aims at identifying rare antibodies that will help elucidating mechanisms of disease and help identifying suitable targets for drug discovery. This will be achieved by an unprecedented high-throughput search for auto-antibodies in blood samples of thousands of participants. The Transfaculty Research Platform Molecular and Cognitive Neurosciences represents Basel's involvement in this Zurich-Basel alliance project. The Platform contributes with a unique combination of functional and structural brain imaging, genetic, behavioral, and biological data from thousands of healthy young participants who underwent detailed neuropsychological assessments. The intelligent interconnection of this database information with the data arising from the large, unselected patient cohort of the University Hospital Zurich will be crucial for the informed decisions that will result in the prioritization of novel drug targets. 1234 1...4
Development of small molecule MSI1/2 inhibitors to treat memory disorders Research Project | 2 Project MembersImported from Grants Tool 4708786
Developing a reward-based biofeedback application for depressed patients using virtual reality Research Project | 1 Project MembersImported from Grants Tool 4695263
Examining mental representations of contamination stimuli in a population with obsessive-compulsive disorder, a data-driven approach Research Project | 2 Project MembersExposure with response prevention (ERP) is the gold standard for treating obsessive-compulsive disorder (OCD) and is recommended by national and international treatment guidelines. Despite recent developments in this approach, a large share of patients remains symptomatic after treatment, discontinue treatment or are reluctant to start treatment at all. One reason might be that the stimulus material used during ERP is not tailored to the patient, so it does not necessarily target the relevant dimensions of the OCD symptomatology. Currently, there exists no contamination OCD (C-OCD) stimuli set that is validated to provoke other emotions than anxiety, that offers a wide range of intensities along different emotions. It is conceivable that other dimensions of the stimuli are of relevance than the theory-driven dimensions rooted in preexisting emotional theories that represent a fixed model of mental representations, and therefore might miss important unknown domain specific dimensions that might be of higher relevance for some patients. This project intends to complement theory-driven approaches by a data-driven approach to identify relevant dimensions of C-OCD triggers by exploring their mental representations. Methodologically, crowdsourced similarity judgements will be implemented that will be analyzed with multidimensional scaling to identify underlying dimensions followed by a crowdsourced dimension-naming task. Further characterizing C-OCD stimuli and their mental representations as well as compiling a freely available database of contamination-OCD cues will inform the design of new personalized ERP approaches that counteract common problems of ERP treatments for OCD.
Oxytocin substitution therapy in patients with central diabetes insipidus: a double-blind randomized-controlled trial the OxyTUTION trial Research Project | 2 Project MembersNo Description available
Feasibility study on the use of Ze 91019 on day-time cognition and quality of life in people with occasional sleep problems Research Project | 2 Project MembersIt is well known that cognitive performance and quality of life can be impaired after nights of little or no sleep (Hudson, 2020) (Roth, 2007). Therefore, people with occasional sleep problems, i.e. with 1-2 nights per week with impaired sleep, can suffer from impaired cognition the following day. Moreover, occasional sleep problems may lead to reduced overall quality of life (Buysse, 2007). Many people with insomnia do not wish to use conventional hypnotic drugs because of concerns about side effects and the risks of tolerance and dependence, and others do not want to spend the time and efforts required with behavioral therapies (Vincent, 2001). Thus, there is an increasing interest in the use of complementary and alternative medicines, such as herbal and dietary supplements, partly because of their natural properties and perceived relative absence of residual effects. Valerian and hop have both been an integral part of traditional medicine for Centuries. Pharmacological and clinical studies are available demonstrating the applicability of Redormin ® 500, a 45% methanolic extract from valerian root and from hop strobiles, in sleep disorders (Abourashed, 2004), (Dimpfel, 2006), (Morin, 2005), (Koetter, 2007). Not only could the effect be visualized through EEG measurements, but also new ideas regarding the mechanism of action were brought forth (Koetter, 2007)). Currently an agonistic effect on central adenosine receptors, and thus a counteracting effect on caffeine induced sleeplessness through the lignans in hydrophilic valerian root extracts is discussed as a potential mechanism of action for valerian root extract (Schumacher, 2002). The studies available mainly focused on the improvement of sleep quality rather than on improvements of cognitive performance and day performance. Therefore, the aim of this feasibility study is to determine the effect of Redormin® 500 on day-time cognition and quality of life in people with occasional sleep problems.
Simulation Hallucinations Using Mixed Reality Research Project | 2 Project MembersBackground: Reality discrimination (RD), the ability to discriminate between perception and imagination, is central to the assessment of psychiatric health, especially in the context of psychotic disorders. Impairments in RD are associated with auditory and visual hallucination proneness in patients with psychotic disorders as well as the general population. However, there are currently no instruments available that allow for the combined assessment of auditory and visual RD performance. Furthermore, RD paradigms are limited in their ability to account for the complex phenomenology of natural hallucinations. More sensitive assessment methods are crucial to improve patient care, diagnosis, and treatment. Objectives: The overall goal of the proposed research is to develop a dual-modality RD paradigm to investigate the cognitive mechanisms underlying visual and auditory hallucinations and their relation to psychotic disorders. The first objective is to simulate hallucinatory perceptual experiences using a novel immersive technology method to manipulate the visual and auditory perception of natural environments. The second objective is to extend this simulation into a dual-modality RD paradigm based on the signal detection framework. Thereafter, the RD paradigm will be applied in healthy adults from the general population (Objective 3) and patients diagnosed with psychotic disorder (Objective 4). Methods: A first study will test the hypothesis that visual and auditory RD performance is associated with hallucination proneness in the general population (N=100). A second study will evaluate visual and auditory RD performance in a sample of patients with psychotic disorders (N=30) and will test the hypothesis that these patients are impaired in RD relative to matched controls from Study 1. In both studies, participants will complete the newly-designed RD paradigm as well as assessments of hallucination proneness and predisposition to psychosis (Study 1) or psychosis severity (Study 2). Expected Value of the Proposed Project: This research will contribute to the understanding of visual and auditory hallucinations and their shared cognitive mechanisms in the general population and patients with psychotic disorders. The novel RD paradigm may provide an improved measure of psychosis proneness that is more objective and behaviorally sensitive to hallucinatory experiences. This research may have important implications for the assessment, treatment, and early detection of psychotic disorders and will provide an ecologically valid framework from which innovative psychological interventions can be developed.
Genome-guided drug identification: A randomized placebo-controlled trial on the influence of fampridine on working memory Research Project | 2 Project MembersBackground: The discrepancy between the urgent need for improved therapeutic compounds and the lack of significant development of novel drugs illustrates the importance of pursuing new strategies aimed at identifying druggable targets related to psychiatric disease. Recent advances in large-scale genetic studies suggest that human genetic discoveries have the potential of translating into novel treatment targets for psychiatric conditions. Aim: To implement a drug repurposing strategy and perform a proof-of-concept clinical trial on the influence of a potassium channel blocker (fampridine) on working memory performance, an intermediate trait of psychiatric disorders. Methods: Guided by recent genetic findings in schizophrenia, we focus on those loci that point to genes targeted by currently approved drugs. As starting point serves the large schizophrenia genome-wide association study that provided genes robustly linked to the risk for the disorder. As intermediate filtering layer serves working memory performance, which is a well-established intermediate phenotype for schizophrenia. Finally, one repurposing candidate, fampridine, is selected and tested for its putative influence on working memory performance in the framework of a randomized placebo-controlled trial in healthy subjects. Expected value: We anticipate that the exponentially increased genetic knowledge of psychiatric disorders together with the use of biologically-informed phenotypes and appropriate data-mining methodology will be a starting point for the identification of novel drug targets and treatments, i.e. the very goal of the present proposal. Should the current randomized control trial turn out positive, it might open new avenues for the treatment of cognitive symptoms in psychiatric disorders with known and hopefully also new and specific potassium channel blockers.
Effects of an exercise and sport intervention among refugees living in a Greek refugee camp: A randomized controlled trial Research Project | 10 Project MembersDue to ongoing political and social conflicts, the number of international refugees has been increasing. Refugees are exposed to severe mental and physical strain, as well as traumatic experiences during their flight. As a consequence, the risk of psychiatric disorders is markedly increased among international refugees with particularities based on gender. International organizations have criticized the lack of early interventions as a key problem, because untreated mental disorders are often difficult to cure at a later stage. Today, exercise and sport have been successfully employed to treat a wide range of psychiatric disorders. With PTSD patients, however, very limited empirical evidence exists, and studies carried out with international refugees are nearly non-existent. In 2017, we have implemented a first pilot one-group pre-test/post-test study in a Greek refugee camp, corroborating the potential benefits of exercise and sport on refugees' mental health and fitness. The proposed study will take place in the Koutsochero refugee camp, located close to the city of Larissa (Greece). The randomized controlled trial will include an exercise and sport intervention group (n=68) and a wait-list control group (n=68). Participants (50% men/women, 16-59 years) will be assessed three times at baseline, immediately post-intervention (after 3 months), and follow-up (after 6 months). In the second year of study, the program will be opened to all camp residents. Exercise and sport will be offered five times per week (60 min/session) for three months. Participants will participate in at least two sessions per week. The program is developed according to the participants' needs and preferences and they will be able to choose between a range of activities. PTSD symptoms will serve as primary outcome. Several secondary outcomes will be assessed, and the project will identify potential gender issues. A strategy will be developed how the exercise and sport program can be continued after the SNIS funding comes to an end, and how the program can be scaled up beyond the borders of the Koutsochero camp.
Learning from the extraordinary: The molecular underpinnings of extreme memorizers Research Project | 2 Project MembersStellen Sie sich vor, Sie könnten sich für jedes Datum seit Jahrzehnten an den Wochentag erinnern und sich wüssten noch, was Sie an jedem dieser Tage getan haben. Was unmöglich klingt, existiert tatsächlich als extrem seltener Befund, genannt Highly Superior Autobiographical Memory (HSAM). Derzeit sind weltweit rund 60 Personen mit HSAM bekannt. Wir werden eine eingehende genetische Analyse von HSAM Individuen durchführen, um den molekularen Mechanismus zu suchen, der diesem extrem stabilen Gedächtnis zugrunde liegt. Bei Erfolg könnten die Ergebnisse unser Verständnis des Gedächtnisses verändern und neue Wege zur Behandlung von Gedächtnisstörungen eröffnen.
Population-wide screens of the immune repertoire: a reverse personalized-medicine approach Research Project | 2 Project MembersAntibodies are crucial for the intact function of the human immune system. For example, they are responsible for the body's defense against bacteria and cancer cells, but are also implicated in a variety of neuropsychiatric disorders. The present driver-project aims at identifying rare antibodies that will help elucidating mechanisms of disease and help identifying suitable targets for drug discovery. This will be achieved by an unprecedented high-throughput search for auto-antibodies in blood samples of thousands of participants. The Transfaculty Research Platform Molecular and Cognitive Neurosciences represents Basel's involvement in this Zurich-Basel alliance project. The Platform contributes with a unique combination of functional and structural brain imaging, genetic, behavioral, and biological data from thousands of healthy young participants who underwent detailed neuropsychological assessments. The intelligent interconnection of this database information with the data arising from the large, unselected patient cohort of the University Hospital Zurich will be crucial for the informed decisions that will result in the prioritization of novel drug targets.
